Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]

• Main Authors: Stefano Bonassi (Author), Giulia Prinzi (Author), Palma Lamonaca (Author), Patrizia Russo (Author), Irene Paximadas (Author), Giuseppe Rasoni (Author), Raffaella Rossi (Author), Marzia Ruggi (Author), Salvatore Malandrino (Author), Maria Sánchez-Flores (Author), Vanessa Valdiglesias (Author), Barbara Benassi (Author), Francesca Pacchierotti (Author), Paola Villani (Author), Martina Panatta (Author), Eugenia Cordelli (Author)
• Format: Book
• Published: BMC, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Numerous health benefits have been attributed to the Ginkgo biloba leaf extract (GBLE), one of the most extensively used phytopharmaceutical drugs worldwide. Recently, concerns of the safety of the extract have been raised after a report from US National Toxicology Program (NTP)...